查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1858036

玻璃體填塞市場按產品類型、填塞持續時間、手術類型和最終用戶分類 - 全球預測 2025-2032

Vitreous Tamponades Market by Product Type, Tamponade Duration, Surgery Type, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，玻璃體填充劑市場規模將達到 2.6418 億美元，複合年成長率為 7.46%。

主要市場統計數據
基準年 2024 1.4856億美元
預計年份：2025年 1.5956億美元
預測年份：2032年 2.6418億美元
複合年成長率 (%) 7.46%

本文簡要介紹了玻璃體填充術的臨床作用、不斷變化的手術環境及其對器械採購和臨床策略的影響。

在玻璃體視網膜手術中，填充物是必不可少的輔助手段，用於穩定視網膜、在玻璃體切除後提供內部填充，並促進視網膜復位和癒合。填充物的選擇受其理化性質、作用持續時間和與特定手術目標的契合度的影響，而外科醫生的偏好和患者的合併症也會影響臨床決策。隨著微創玻璃體手術技術的日益成熟，填充物的選擇擴大被納入圍手術全期方案，以最佳化解剖和功能方面的手術效果。

透過全面整合臨床、監管和供應鏈轉型，重新定義玻璃體視網膜護理領域的競爭優勢和手術實踐。

玻璃體視網膜填充領域正經歷著一場變革性的轉變，其驅動力包括臨床創新、技術改進和供應鏈重組。臨床上，小切口玻璃體手術和成像設備的整合拓展了填充適應症和技術方法，促使製造商相應地調整配方和給藥機制。這種技術上的相互作用促進了設備工程師和視網膜專家之間的跨學科合作，加速了產品性能和操作特性的迭代改進。

本文簡要分析了2025年美國累積關稅措施如何擾亂玻璃體填塞生態系統的供應鏈、採購流程和策略採購決策。

美國2025年實施的關稅政策，為醫療設備和特殊液體供應鏈帶來了疊加成本和管理複雜性，影響了籌資策略和供應商談判。這些關稅影響了用於填塞物生產的進口原料和成品，促使製造商評估替代貨源、調整庫存緩衝，並加強與委託製造的溝通，以確保供應的連續性。醫院和門診手術中心則透過審查供應商協議、尋求合約保護以應對突發的投入成本波動，以及尋找物流佈局更有利的替代供應商來應對這些關稅政策。

詳細的細分分析揭示了產品類型、填塞持續時間、手術適應症和最終用戶環境如何共同影響臨床和採購優先事項。

產品類型、填充持續時間、手術、適應症和最終用戶環境揭示了不同的需求促進因素和臨床偏好，突顯了技術創新和政策如何與臨床實踐相互作用。按產品類型分類，市場分析涵蓋了油氣、重質矽油和矽油。每類產品都有獨特的風險效益比，外科醫師必須權衡病例的複雜性和術後體位要求。膨脹氣體可提供可預測的暫時性填充，特別適用於黃斑裂孔和視網膜切開術；而重質矽油則可在複雜的視網膜剝離中提供有利的下視網膜支撐。標準矽油適用於需要長期內部填充且長期穩定性至關重要的病例。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 生物相容性的提高使得重質液態矽油在複雜視網膜剝離病例中的應用日益廣泛。
  • 增加對聚合物基可生物分解玻璃體替代物的投資，以避免二次摘除手術
  • 糖尿病視網膜病變盛行率的上升推動了對具有更長充盈時間的高級氣體填充物的需求。
  • 開發一種用於玻璃體置換術的熱響應智慧水凝膠，以提高手術效率
  • 人口老化和眼科疾病發病率的上升推動了亞太地區玻璃體手術和眼內填充術的成長。
  • 將即時術中OCT引導整合到玻璃體填充物選擇中，以最佳化術後視網膜復位

第6章美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 玻璃體填塞市場（依產品類型分類）

  • 膨脹氣體
  • 重矽油
  • 矽油

9. 按填塞持續時間分類的玻璃體填塞市場

  • 長效
  • 中時行動
  • 短效

第10章 依手術類型分類的玻璃體填塞市場

  • 黃斑裂孔和視網膜前膜
  • 增殖性糖尿病視網膜病變
  • 視網膜剝離

第11章 依最終用戶分類的玻璃體填塞市場

  • 門診手術中心
  • 醫院

第12章 各地區玻璃體填塞市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 玻璃體填塞市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國玻璃體填塞市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Alcon Laboratories, Inc.
    • Bausch+Lomb Incorporated
    • B. Braun Melsungen AG
    • Carl Zeiss Meditec AG
    • Geuder AG
    • FCI Ophthalmics, Inc.
    • Synergetics USA, Inc.
    • Fluoron GmbH
    • DORC International BV
    • Ophthalmic Innovation International, LLC
Product Code: MRR-C002B1C9967D

The Vitreous Tamponades Market is projected to grow by USD 264.18 million at a CAGR of 7.46% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 148.56 million
Estimated Year [2025] USD 159.56 million
Forecast Year [2032] USD 264.18 million
CAGR (%) 7.46%

Concise introduction to vitreous tamponades that explains their clinical role, evolving surgical context, and implications for procurement and clinical strategy

Vitreous tamponades are foundational adjuncts in vitreoretinal surgery, deployed to stabilize the retina, provide internal tamponade after vitreous removal, and facilitate reattachment and healing. Their selection hinges on physicochemical properties, duration of action, and compatibility with specific surgical objectives, while surgeon preference and patient comorbidities shape clinical decision-making. As minimally invasive vitrectomy techniques mature, tamponade choice increasingly integrates with perioperative protocols to optimize anatomical and functional outcomes.

Recent clinical practice has emphasized personalized tamponade strategies to address complex pathologies such as retinal detachment, proliferative diabetic retinopathy, and macular hole repair. Concurrent advancements in intraoperative visualization and instrument design have altered surgery dynamics, prompting clinicians and procurement teams to reassess product portfolios and supply chains. As an executive summary, this introduction frames the technology, clinical utility, and systemic forces reshaping how vitreous tamponades are selected, procured, and deployed in contemporary ophthalmic care.

Comprehensive synthesis of the transformative clinical, regulatory, and supply chain shifts that are redefining competitive advantage and surgical practice in vitreoretinal care

The landscape for vitreous tamponades has experienced transformative shifts driven by clinical innovation, procedural refinement, and supply-chain realignment. On the clinical front, the integration of smaller-gauge vitrectomy systems and enhanced imaging modalities has expanded the indications and technical approaches for tamponade use, prompting manufacturers to adapt formulations and delivery mechanisms accordingly. This technological interplay has encouraged cross-disciplinary collaboration between device engineers and retinal specialists, accelerating iterative improvements in product performance and handling characteristics.

Equally consequential are regulatory and reimbursement dynamics that have pushed industry actors to demonstrate comparative effectiveness, safety profiles, and value in constrained healthcare budgets. Simultaneously, surgical teams have trended toward evidence-driven selection criteria, favoring tamponades that balance ease of use with predictable clinical outcomes. Supply chain optimization and strategic partnerships have evolved in parallel, as companies seek resilience through regional manufacturing, diversified sourcing of specialty components, and closer alignment with distributor networks. These shifts together redefine competitive advantage and set new expectations for product stewardship and lifecycle management.

Analytical overview of how the cumulative United States tariff measures in 2025 disrupted supply chains, procurement practices, and strategic sourcing decisions across the vitreous tamponade ecosystem

United States tariff measures implemented in 2025 introduced layered costs and administrative complexity across the medical device and specialty fluid supply chains, influencing procurement strategies and vendor negotiations. These tariff actions affected imported raw materials and finished products used in tamponade manufacturing, prompting manufacturers to evaluate sourcing alternatives, adjust inventory buffers, and intensify dialogue with contract manufacturers to preserve continuity of supply. Hospitals and ambulatory surgical centers responded by reassessing vendor agreements, seeking contractual protections against sudden input cost changes, and exploring alternative suppliers with more favorable logistical footprints.

In response to these trade policy shifts, some manufacturers expedited nearshoring initiatives and invested in regional production capacity to mitigate exposure to import tariffs and transit disruptions. Payers and health systems, recognizing potential cost pressures, emphasized procurement centralization and value-based contracting to manage total cost of care. Clinically, providers prioritized evidence that demonstrated predictable outcomes across tamponade types to justify continuity in product selection despite changing cost structures. The cumulative effect transformed negotiation dynamics, elevated the importance of supply chain transparency, and increased the premium on operational agility across the ecosystem.

In-depth segmentation analysis revealing how product type, tamponade duration, surgery indication, and end-user setting converge to shape clinical and procurement priorities

Segmentation insights reveal differentiated drivers of demand and clinical preference across product, duration, surgery type, and end-user dimensions, highlighting where innovation and policy intersect with clinical practice. Based on Product Type the market is studied across Expansile Gas, Heavy Silicone Oil, and Silicone Oil, and each class brings a distinct risk-benefit profile that surgeons weigh relative to case complexity and postoperative positioning requirements. Expansile gases offer predictable temporary tamponade with particular utility in macular hole and retinotomy cases, while heavy silicone oils provide advantageous inferior retinal support in complex detachments. Standard silicone oils remain a workhorse for cases requiring prolonged internal tamponade when long-term stability is essential.

Based on Tamponade Duration the market is studied across Long Acting, Medium Acting, and Short Acting, with duration influencing postoperative management, follow-up scheduling, and patient counseling. Short-acting agents reduce time to visual rehabilitation in select procedures but may be inadequate for advanced proliferative disease, whereas long-acting agents facilitate extended retinal apposition at the cost of additional follow-up and potential removal procedures. Based on Surgery Type the market is studied across Macular Hole And Epiretinal Membrane, Proliferative Diabetic Retinopathy, and Retinal Detachment, and each surgical indication imposes unique demands on tamponade physical properties, emulsification resistance, and optical clarity. Surgical complexity, reoperation risk, and anatomical location of pathology are key determinants of tamponade selection. Based on End User the market is studied across Ambulatory Surgical Centers and Hospitals, and procurement preferences diverge between these settings: ambulatory centers often prioritize streamlined logistics, single-use convenience, and rapid turnover, while hospitals emphasize product versatility, inventory breadth, and integration with complex care pathways. Together, these segmentation lenses illuminate where clinical need, operational constraints, and product attributes converge to shape purchasing and development priorities.

Nuanced regional perspectives that explain how clinical adoption, regulatory diversity, and procurement models differ across the Americas, Europe Middle East & Africa, and Asia-Pacific

Regional dynamics shape clinical adoption patterns, regulatory pathways, and commercial strategies in distinct ways across the Americas, Europe, Middle East & Africa, and Asia-Pacific, creating differentiated opportunities for market entrants and established suppliers. In the Americas, clinical protocols and reimbursement environments support rapid adoption of procedural innovations, while advanced tertiary centers drive demand for specialty tamponades suited to complex retinal surgery. Regulatory expectations emphasize robust clinical evidence and post-market surveillance, prompting manufacturers to invest in localized regulatory expertise and clinical partnerships.

Across Europe, Middle East & Africa, regulatory heterogeneity and varied infrastructure across countries necessitate adaptive market approaches, including flexible packaging, tiered pricing, and targeted clinician education. Health systems in certain regions prioritize cost containment, incentivizing products that demonstrate procedural efficiency and predictable outcomes. The Asia-Pacific region exhibits a mix of high-volume surgical centers and rapidly expanding access to vitreoretinal care, driven by rising prevalence of diabetes and expanding surgical capacity. Here, scalable manufacturing and regional regulatory navigation are critical to meeting diverse clinical needs and procurement models. Recognizing these regional nuances enables manufacturers and health systems to align commercialization, clinical evidence generation, and distribution strategies for maximum impact.

Strategic competitive analysis showing how R&D focus, manufacturing resilience, and clinical partnerships are shaping company positioning and value propositions

Competitive dynamics in the vitreous tamponade space reflect a balance between specialized product innovation, manufacturing scale, and clinical trust. Leading manufacturers concentrate R&D on formulations that reduce emulsification, enhance optical clarity, and improve ease of removal, while also investing in delivery systems and sterile packaging that align with modern operating room workflows. Firms positioning themselves as reliable supply partners emphasize manufacturing redundancy, quality management systems, and transparent raw-material sourcing to reassure hospital procurement teams and distributors.

Strategic partnerships between device manufacturers and clinical centers have become a focal avenue for evidence generation and product refinement, allowing iterative feedback to inform both clinical training and product design. Additionally, a growing number of entrants target adjacent value-chain roles, such as specialty chemistry suppliers and contract manufacturing organizations that provide tailored blends and small-batch flexibility. Competitive advantage increasingly rests on the ability to demonstrate real-world safety, to rapidly adapt to regional regulatory requirements, and to offer integrated service models that include clinician education, inventory management, and post-market data collection.

Practical and prioritized recommendations for manufacturers, providers, and purchasers to strengthen clinical value, supply resilience, and commercial agility in vitreoretinal care

Leaders within industry and healthcare delivery should adopt a proactive posture that aligns clinical evidence, supply resilience, and commercial agility to capture long-term value. Manufacturers are advised to prioritize development of formulations with demonstrable safety and handling advantages, while concurrently building regional manufacturing capabilities to mitigate trade-policy volatility. Investing in clinician education and structured post-market studies will accelerate adoption by legitimizing product differentiation and addressing practical intraoperative questions.

Providers and purchasers should negotiate contracts that incorporate supply continuity assurances, quality thresholds, and transparent pricing mechanisms to manage exposure to input cost variability. Collaborative models that involve early clinician input into product design, bundled procurement programs, and shared risk arrangements can reduce friction and align incentives across the care pathway. Finally, stakeholders should develop contingency plans that integrate diversified sourcing, stock optimization, and rapid escalation protocols to preserve surgical capacity during supply disruptions, thereby protecting patient outcomes and institutional reputations.

Transparent research methodology that integrates primary clinical perspectives with secondary regulatory and supply chain analysis to produce actionable and validated insights

The underlying research combines primary qualitative inputs with structured secondary analysis to ensure findings are both clinically informed and operationally relevant. Primary methods included semi-structured interviews with retinal surgeons, procurement leaders, and operating room managers to capture real-world decision drivers, handling preferences, and logistical constraints. These conversations were complemented by expert advisory sessions that validated emerging trends and interpretation of regulatory developments.

Secondary analysis leveraged peer-reviewed clinical literature, regulatory filings, device labeling, and trade publications to map technology characteristics and clinical outcomes, while supply-chain mapping identified critical nodes and sourcing dependencies. Data synthesis emphasized triangulation between clinical feedback, regulatory context, and distribution realities to produce actionable insights. Throughout the process, attention was given to data provenance, conflict-of-interest disclosures, and methodological transparency to support credible, reproducible conclusions for executives and clinical leaders alike.

Concise concluding synthesis that underscores the clinical importance of tamponade selection and the strategic imperatives for manufacturers and healthcare providers

In conclusion, vitreous tamponades remain a vital component of modern vitreoretinal surgery, and their evolution is driven by intersecting forces of clinical innovation, supply-chain dynamics, and policy shifts. Clinical practice is trending toward more tailored tamponade selection informed by procedure type, anticipated duration, and patient factors, while manufacturers must demonstrate both product performance and operational reliability to secure institutional and surgeon trust. The commercial landscape rewards agility in regulatory navigation, localized manufacturing strategy, and sustained clinician engagement to substantiate therapeutic value.

Stakeholders who act decisively to strengthen evidence generation, diversify sourcing, and align commercial models with clinical workflows will be best positioned to influence standards of care and to protect continuity of access. As surgical techniques and patient expectations evolve, the capacity to translate scientific advances into robust, scalable products and dependable service models will determine who shapes the next generation of vitreous tamponade practice.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increased adoption of heavy liquid silicone oils for complex retinal detachment cases driven by enhanced biocompatibility
  • 5.2. Rising investment in polymer-based biodegradable vitreous substitutes aiming to eliminate secondary removal surgeries
  • 5.3. Growing prevalence of diabetic retinopathy fueling demand for advanced gas-based tamponades with extended fill duration
  • 5.4. Ongoing development of thermoresponsive smart hydrogels for vitreous replacement to improve surgical handling efficiency
  • 5.5. Expansion of vitrectomy and tamponade procedures in Asia Pacific markets due to aging populations and eye disease incidence
  • 5.6. Integration of real-time intraoperative OCT guidance in vitreous tamponade selection to optimize post-surgical retinal reattachment

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Vitreous Tamponades Market, by Product Type

  • 8.1. Expansile Gas
  • 8.2. Heavy Silicone Oil
  • 8.3. Silicone Oil

9. Vitreous Tamponades Market, by Tamponade Duration

  • 9.1. Long Acting
  • 9.2. Medium Acting
  • 9.3. Short Acting

10. Vitreous Tamponades Market, by Surgery Type

  • 10.1. Macular Hole And Epiretinal Membrane
  • 10.2. Proliferative Diabetic Retinopathy
  • 10.3. Retinal Detachment

11. Vitreous Tamponades Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals

12. Vitreous Tamponades Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Vitreous Tamponades Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Vitreous Tamponades Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Alcon Laboratories, Inc.
    • 15.3.2. Bausch + Lomb Incorporated
    • 15.3.3. B. Braun Melsungen AG
    • 15.3.4. Carl Zeiss Meditec AG
    • 15.3.5. Geuder AG
    • 15.3.6. FCI Ophthalmics, Inc.
    • 15.3.7. Synergetics USA, Inc.
    • 15.3.8. Fluoron GmbH
    • 15.3.9. DORC International B.V.
    • 15.3.10. Ophthalmic Innovation International, LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL VITREOUS TAMPONADES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS VITREOUS TAMPONADES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA VITREOUS TAMPONADES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. VITREOUS TAMPONADES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. VITREOUS TAMPONADES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. VITREOUS TAMPONADES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL VITREOUS TAMPONADES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL VITREOUS TAMPONADES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY EXPANSILE GAS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY EXPANSILE GAS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY EXPANSILE GAS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY EXPANSILE GAS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY EXPANSILE GAS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY EXPANSILE GAS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY HEAVY SILICONE OIL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY HEAVY SILICONE OIL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY HEAVY SILICONE OIL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY HEAVY SILICONE OIL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY HEAVY SILICONE OIL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY HEAVY SILICONE OIL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY SILICONE OIL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY SILICONE OIL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY SILICONE OIL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY SILICONE OIL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY SILICONE OIL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY SILICONE OIL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY LONG ACTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY LONG ACTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY LONG ACTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY LONG ACTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY LONG ACTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY LONG ACTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY MEDIUM ACTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY MEDIUM ACTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY MEDIUM ACTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY MEDIUM ACTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY MEDIUM ACTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY MEDIUM ACTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY SHORT ACTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY SHORT ACTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY SHORT ACTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY SHORT ACTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY SHORT ACTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY SHORT ACTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY MACULAR HOLE AND EPIRETINAL MEMBRANE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY MACULAR HOLE AND EPIRETINAL MEMBRANE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY MACULAR HOLE AND EPIRETINAL MEMBRANE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY MACULAR HOLE AND EPIRETINAL MEMBRANE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY MACULAR HOLE AND EPIRETINAL MEMBRANE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY MACULAR HOLE AND EPIRETINAL MEMBRANE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY PROLIFERATIVE DIABETIC RETINOPATHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY PROLIFERATIVE DIABETIC RETINOPATHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY PROLIFERATIVE DIABETIC RETINOPATHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY PROLIFERATIVE DIABETIC RETINOPATHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY PROLIFERATIVE DIABETIC RETINOPATHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY PROLIFERATIVE DIABETIC RETINOPATHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY RETINAL DETACHMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY RETINAL DETACHMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY RETINAL DETACHMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY RETINAL DETACHMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY RETINAL DETACHMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY RETINAL DETACHMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. AMERICAS VITREOUS TAMPONADES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 82. AMERICAS VITREOUS TAMPONADES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 83. AMERICAS VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 84. AMERICAS VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 85. AMERICAS VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2018-2024 (USD MILLION)
  • TABLE 86. AMERICAS VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2025-2032 (USD MILLION)
  • TABLE 87. AMERICAS VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
  • TABLE 88. AMERICAS VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2025-2032 (USD MILLION)
  • TABLE 89. AMERICAS VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 90. AMERICAS VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. NORTH AMERICA VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 94. NORTH AMERICA VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2018-2024 (USD MILLION)
  • TABLE 96. NORTH AMERICA VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2025-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
  • TABLE 98. NORTH AMERICA VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2025-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 100. NORTH AMERICA VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. LATIN AMERICA VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 104. LATIN AMERICA VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2018-2024 (USD MILLION)
  • TABLE 106. LATIN AMERICA VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2025-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
  • TABLE 108. LATIN AMERICA VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2025-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 110. LATIN AMERICA VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA VITREOUS TAMPONADES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA VITREOUS TAMPONADES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2018-2024 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2025-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2025-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 121. EUROPE VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. EUROPE VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. EUROPE VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 124. EUROPE VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 125. EUROPE VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2018-2024 (USD MILLION)
  • TABLE 126. EUROPE VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2025-2032 (USD MILLION)
  • TABLE 127. EUROPE VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
  • TABLE 128. EUROPE VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2025-2032 (USD MILLION)
  • TABLE 129. EUROPE VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 130. EUROPE VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. MIDDLE EAST VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 134. MIDDLE EAST VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2018-2024 (USD MILLION)
  • TABLE 136. MIDDLE EAST VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2025-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
  • TABLE 138. MIDDLE EAST VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2025-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 140. MIDDLE EAST VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 141. AFRICA VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. AFRICA VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. AFRICA VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 144. AFRICA VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 145. AFRICA VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2018-2024 (USD MILLION)
  • TABLE 146. AFRICA VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2025-2032 (USD MILLION)
  • TABLE 147. AFRICA VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
  • TABLE 148. AFRICA VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2025-2032 (USD MILLION)
  • TABLE 149. AFRICA VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 150. AFRICA VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2018-2024 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2025-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. ASEAN VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. ASEAN VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. ASEAN VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. ASEAN VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 167. ASEAN VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2018-2024 (USD MILLION)
  • TABLE 168. ASEAN VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2025-2032 (USD MILLION)
  • TABLE 169. ASEAN VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. ASEAN VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. ASEAN VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 172. ASEAN VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 173. GCC VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GCC VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GCC VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. GCC VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. GCC VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2018-2024 (USD MILLION)
  • TABLE 178. GCC VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2025-2032 (USD MILLION)
  • TABLE 179. GCC VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
  • TABLE 180. GCC VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2025-2032 (USD MILLION)
  • TABLE 181. GCC VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 182. GCC VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPEAN UNION VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPEAN UNION VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPEAN UNION VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPEAN UNION VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPEAN UNION VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 193. BRICS VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. BRICS VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. BRICS VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. BRICS VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 197. BRICS VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2018-2024 (USD MILLION)
  • TABLE 198. BRICS VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2025-2032 (USD MILLION)
  • TABLE 199. BRICS VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. BRICS VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. BRICS VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 202. BRICS VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 203. G7 VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. G7 VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. G7 VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. G7 VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. G7 VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2018-2024 (USD MILLION)
  • TABLE 208. G7 VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2025-2032 (USD MILLION)
  • TABLE 209. G7 VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. G7 VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2025-2032 (USD MILLION)
  • TABLE 211. G7 VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 212. G7 VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 213. NATO VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. NATO VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. NATO VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. NATO VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. NATO VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2018-2024 (USD MILLION)
  • TABLE 218. NATO VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2025-2032 (USD MILLION)
  • TABLE 219. NATO VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. NATO VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. NATO VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 222. NATO VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL VITREOUS TAMPONADES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. UNITED STATES VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. UNITED STATES VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. UNITED STATES VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2018-2024 (USD MILLION)
  • TABLE 228. UNITED STATES VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2025-2032 (USD MILLION)
  • TABLE 229. UNITED STATES VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. UNITED STATES VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. UNITED STATES VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. UNITED STATES VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. CANADA VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. CANADA VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. CANADA VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2018-2024 (USD MILLION)
  • TABLE 236. CANADA VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2025-2032 (USD MILLION)
  • TABLE 237. CANADA VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. CANADA VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. CANADA VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. CANADA VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 241. MEXICO VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. MEXICO VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. MEXICO VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2018-2024 (USD MILLION)
  • TABLE 244. MEXICO VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2025-2032 (USD MILLION)
  • TABLE 245. MEXICO VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. MEXICO VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. MEXICO VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 248. MEXICO VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 249. BRAZIL VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. BRAZIL VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. BRAZIL VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2018-2024 (USD MILLION)
  • TABLE 252. BRAZIL VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2025-2032 (USD MILLION)
  • TABLE 253. BRAZIL VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. BRAZIL VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. BRAZIL VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. BRAZIL VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 257. UNITED KINGDOM VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. UNITED KINGDOM VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. UNITED KINGDOM VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2018-2024 (USD MILLION)
  • TABLE 260. UNITED KINGDOM VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2025-2032 (USD MILLION)
  • TABLE 261. UNITED KINGDOM VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. UNITED KINGDOM VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. UNITED KINGDOM VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. UNITED KINGDOM VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 265. GERMANY VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. GERMANY VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. GERMANY VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2018-2024 (USD MILLION)
  • TABLE 268. GERMANY VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2025-2032 (USD MILLION)
  • TABLE 269. GERMANY VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. GERMANY VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. GERMANY VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 272. GERMANY VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 273. FRANCE VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. FRANCE VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. FRANCE VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2018-2024 (USD MILLION)
  • TABLE 276. FRANCE VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2025-2032 (USD MILLION)
  • TABLE 277. FRANCE VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. FRANCE VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. FRANCE VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. FRANCE VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. RUSSIA VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. RUSSIA VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. RUSSIA VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2018-2024 (USD MILLION)
  • TABLE 284. RUSSIA VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2025-2032 (USD MILLION)
  • TABLE 285. RUSSIA VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. RUSSIA VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. RUSSIA VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 288. RUSSIA VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 289. ITALY VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. ITALY VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. ITALY VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2018-2024 (USD MILLION)
  • TABLE 292. ITALY VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2025-2032 (USD MILLION)
  • TABLE 293. ITALY VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. ITALY VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. ITALY VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 296. ITALY VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 297. SPAIN VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. SPAIN VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. SPAIN VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2018-2024 (USD MILLION)
  • TABLE 300. SPAIN VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2025-2032 (USD MILLION)
  • TABLE 301. SPAIN VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. SPAIN VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. SPAIN VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. SPAIN VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 305. CHINA VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 306. CHINA VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 307. CHINA VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2018-2024 (USD MILLION)
  • TABLE 308. CHINA VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2025-2032 (USD MILLION)
  • TABLE 309. CHINA VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
  • TABLE 310. CHINA VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2025-2032 (USD MILLION)
  • TABLE 311. CHINA VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 312. CHINA VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 313. INDIA VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. INDIA VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 315. INDIA VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2018-2024 (USD MILLION)
  • TABLE 316. INDIA VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2025-2032 (USD MILLION)
  • TABLE 317. INDIA VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
  • TABLE 318. INDIA VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2025-2032 (USD MILLION)
  • TABLE 319. INDIA VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 320. INDIA VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 321. JAPAN VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 322. JAPAN VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 323. JAPAN VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2018-2024 (USD MILLION)
  • TABLE 324. JAPAN VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2025-2032 (USD MILLION)
  • TABLE 325. JAPAN VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
  • TABLE 326. JAPAN VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2025-2032 (USD MILLION)
  • TABLE 327. JAPAN VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 328. JAPAN VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 329. AUSTRALIA VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 330. AUSTRALIA VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 331. AUSTRALIA VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2018-2024 (USD MILLION)
  • TABLE 332. AUSTRALIA VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2025-2032 (USD MILLION)
  • TABLE 333. AUSTRALIA VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2018-2024 (USD MILLION)
  • TABLE 334. AUSTRALIA VITREOUS TAMPONADES MARKET SIZE, BY SURGERY TYPE, 2025-2032 (USD MILLION)
  • TABLE 335. AUSTRALIA VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 336. AUSTRALIA VITREOUS TAMPONADES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 337. SOUTH KOREA VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 338. SOUTH KOREA VITREOUS TAMPONADES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 339. SOUTH KOREA VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2018-2024 (USD MILLION)
  • TABLE 340. SOUTH KOREA VITREOUS TAMPONADES MARKET SIZE, BY TAMPONADE DURATION, 2025-2032 (U